1. Home
  2. CPSS vs GNLX Comparison

CPSS vs GNLX Comparison

Compare CPSS & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

N/A

Current Price

$7.57

Market Cap

186.1M

Sector

Finance

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

N/A

Current Price

$2.63

Market Cap

124.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPSS
GNLX
Founded
1991
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.1M
124.8M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
CPSS
GNLX
Price
$7.57
$2.63
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$19.75
AVG Volume (30 Days)
9.0K
150.4K
Earning Date
06-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.10
EPS
0.59
N/A
Revenue
$393,506,000.00
$8,000.00
Revenue This Year
$147.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.81
N/A
Revenue Growth
11.79
N/A
52 Week Low
$6.67
$1.99
52 Week High
$10.51
$8.54

Technical Indicators

Market Signals
Indicator
CPSS
GNLX
Relative Strength Index (RSI) 35.66 43.94
Support Level $7.47 $2.54
Resistance Level $8.60 $2.80
Average True Range (ATR) 0.26 0.17
MACD -0.07 0.02
Stochastic Oscillator 10.58 17.20

Price Performance

Historical Comparison
CPSS
GNLX

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: